Pollard S - Search Results

1

Genetic testing for hereditary cancer syndromes: patient recommendations for improved risk communication.

Pollard S, Kalloger S, Weymann D, Sun S, Nuk J, Schrader KA, Regier DA. Pollard S, et al. Health Expect. 2020 Aug;23(4):884-892. doi: 10.1111/hex.13062. Epub 2020 Apr 27. Health Expect. 2020. PMID: 32338425 Free PMC article.

2

Balancing uncertainty with patient autonomy in precision medicine.

Pollard S, Sun S, Regier DA. Pollard S, et al. Nat Rev Genet. 2019 May;20(5):251-252. doi: 10.1038/s41576-019-0111-9. Nat Rev Genet. 2019. PMID: 30872766 No abstract available.

3

Allocating healthcare resources to genomic testing in Canada: latest evidence and current challenges.

Weymann D, Dragojlovic N, Pollard S, Regier DA. Weymann D, et al. Among authors: pollard s. J Community Genet. 2022 Oct;13(5):467-476. doi: 10.1007/s12687-019-00428-5. Epub 2019 Jul 5. J Community Genet. 2022. PMID: 31273679 Free PMC article.

4

Genomic Testing for Relapsed and Refractory Lymphoid Cancers: Understanding Patient Values.

Costa S, Regier DA, Raymakers AJN, Pollard S. Costa S, et al. Among authors: pollard s. Patient. 2021 Mar;14(2):187-196. doi: 10.1007/s40271-020-00448-1. Patient. 2021. PMID: 32875479 Free PMC article.

5

Toward the diagnosis of rare childhood genetic diseases: what do parents value most?

Pollard S, Weymann D, Dunne J, Mayanloo F, Buckell J, Buchanan J, Wordsworth S, Friedman JM, Stockler-Ipsiroglu S, Dragojlovic N, Elliott AM, Harrison M, Lynd LD, Regier DA. Pollard S, et al. Eur J Hum Genet. 2021 Oct;29(10):1491-1501. doi: 10.1038/s41431-021-00882-1. Epub 2021 Apr 26. Eur J Hum Genet. 2021. PMID: 33903739 Free PMC article.

6

Correction to: Toward the diagnosis of rare childhood genetic diseases: what do parents value most?

Pollard S, Weymann D, Dunne J, Mayanloo F, Buckell J, Buchanan J, Wordsworth S, Friedman JM, Stockler-Ipsiroglu S, Dragojlovic N, Elliott AM, Harrison M, Lynd LD, Regier DA. Pollard S, et al. Eur J Hum Genet. 2021 Oct;29(10):1589. doi: 10.1038/s41431-021-00925-7. Eur J Hum Genet. 2021. PMID: 34145384 Free PMC article. No abstract available.

7

Clinical and cost outcomes following genomics-informed treatment for advanced cancers.

Weymann D, Pollard S, Chan B, Titmuss E, Bohm A, Laskin J, Jones SJM, Pleasance E, Nelson J, Fok A, Lim H, Karsan A, Renouf DJ, Schrader KA, Sun S, Yip S, Schaeffer DF, Marra MA, Regier DA. Weymann D, et al. Among authors: pollard s. Cancer Med. 2021 Aug;10(15):5131-5140. doi: 10.1002/cam4.4076. Epub 2021 Jun 21. Cancer Med. 2021. PMID: 34152087 Free PMC article.

8

Stakeholder Perspectives on Navigating Evidentiary and Decision Uncertainty in Precision Oncology.

Pollard S, Dunne J, Costa S, Regier DA. Pollard S, et al. J Pers Med. 2022 Jan 1;12(1):22. doi: 10.3390/jpm12010022. J Pers Med. 2022. PMID: 35055337 Free PMC article.

9

Cost-Effectiveness of Molecularly Guided Treatment in Diffuse Large B-Cell Lymphoma (DLBCL) in Patients under 60.

Regier DA, Chan B, Costa S, Scott DW, Steidl C, Connors JM, Karsan A, Marra MA, Kridel R, Cromwell I, Pollard S. Regier DA, et al. Among authors: pollard s. Cancers (Basel). 2022 Feb 12;14(4):908. doi: 10.3390/cancers14040908. Cancers (Basel). 2022. PMID: 35205656 Free PMC article.

10

Defining a Core Data Set for the Economic Evaluation of Precision Oncology.

Pollard S, Weymann D, Chan B, Ehman M, Wordsworth S, Buchanan J, Hanna TP, Ho C, Lim HJ, Lorgelly PK, Raymakers AJN, McCabe C, Regier DA. Pollard S, et al. Value Health. 2022 Aug;25(8):1371-1380. doi: 10.1016/j.jval.2022.01.005. Epub 2022 Feb 23. Value Health. 2022. PMID: 35216902 Free article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

560 results

Search Page

Filters